Applied Therapeutics Inc Quick Ratio (APLT) starting from the third quarter 2025 to third quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Applied Therapeutics Inc   (NASDAQ: APLT)

Applied Therapeutics Inc 's Quick Ratio

APLT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2025, Quick Ratio fell to 0.36 a new company low.

Within Major Pharmaceutical Preparations industry 368 other companies have achieved higher Quick Ratio than Applied Therapeutics Inc in third quarter 2025. While Quick Ratio total ranking in the third quarter 2025 has deteriorated compared to the prior quarter from 1003 to 2215.

Explain Quick Ratio?
How much Cash & cash equivalents APLT´s has?
What are APLT´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

APLT Quick Ratio (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2		 (Mar 31 2025)
Q1		 (Dec 31 2024)
Q4		 (Sep 30 2024)
Q3
Y / Y Current Liabilities Change -66.75 % -67.94 % -78.59 % -61.65 % 78.31 %
Y / Y Cash & cash equivalent Change -87.92 % -75.1 % -65.35 % 59.12 % 163.95 %
Quick Ratio MRQ 0.36 1.71 2.83 2.91 1
APLT's Total Ranking # 2215 # 1003 # 585 # 853 # 1607
Seq. Current Liabilities Change 85.37 % -1.2 % -34.18 % -72.42 % 78.78 %
Seq. Cash & cash equivalent Change -60.73 % -40.07 % -36.07 % -19.69 % -19.09 %



Quick Ratio third quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 369
Healthcare Sector # 697
Overall Market # 2215


Quick Ratio Statistics
High Average Low
19.52 3.95 0.36
(Sep 30 2019)   (Sep 30 2025)




Financial Statements
Applied Therapeutics Inc 's Current Liabilities $ 33 Millions Visit APLT's Balance sheet
Applied Therapeutics Inc 's Cash & cash equivalent $ 12 Millions Visit APLT's Balance sheet
Source of APLT's Sales Visit APLT's Sales by Geography


Cumulative Applied Therapeutics Inc 's Quick Ratio

APLT's Quick Ratio for the trailling 12 Months

APLT Quick Ratio

 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months		 (Mar 31 2025)
12 Months		 (Dec 31 2024)
12 Months		 (Sep 30 2024)
12 Months
Y / Y Current Liabilities TTM Growth -69 % -39.09 % -22.58 % 28.2 % 82.69 %
Y / Y Cash & cash equivalent TTM Growth -58.67 % -27.13 % 30.35 % 206.36 % 229.81 %
Quick Ratio TTM 1.8 1.6 1.76 1.68 1.35
Total Ranking TTM # 3133 # 2679 # 2119 # 3046 # 2870
Seq. Current Liabilities TTM Growth -40.79 % -18.84 % -24.83 % -14.18 % 16.34 %
Seq. Cash & cash equivalent TTM Growth -33.5 % -26.13 % -21.42 % 7.07 % 17.25 %

Quick ratio ranking by company, industry and sector >> Back to APLT Financial Strength Comparisons >> Go to Compare APLT Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Applied Therapeutics Inc 's average Cash & cash equivalent, this led to increase in in Applied Therapeutics Inc 's Quick Ratio to 1.8, Quick Ratio remained below APLT average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 411 other companies have achieved higher Quick Ratio than Applied Therapeutics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2025 from 2679 to 3133.

Explain Quick Ratio?
How much Cash & cash equivalents APLT´s has?
What are APLT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 412
Healthcare Sector # 851
Within the Market # 3133


trailing twelve months Quick Ratio Statistics
High Average Low
7.6 3.03 0.7
(Jun 30 2020)   (Dec 31 2023)




Companies with similar Quick Ratio in the quarter ending Sep 30 2025, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2025 MRQ Cash & cash equivalentSep 30 2025 MRQ Current Liabilities
Integrated Biopharma Inc  0.99 $ 4.732  Millions$ 4.764  Millions
Beyondspring Inc   0.99 $ 12.483  Millions$ 12.579  Millions
Kamada Ltd   0.99 $ 71.997  Millions$ 72.931  Millions
Serina Therapeutics Inc   0.98 $ 8.620  Millions$ 8.789  Millions
Keenova Therapeutics Plc  0.98 $ 1,047.900  Millions$ 1,071.100  Millions
Ani Pharmaceuticals Inc  0.97 $ 262.610  Millions$ 270.555  Millions
Bioxcel Therapeutics Inc   0.96 $ 36.176  Millions$ 37.804  Millions
Clene Inc   0.95 $ 7.925  Millions$ 8.306  Millions
Nurix Therapeutics Inc   0.95 $ 78.438  Millions$ 82.350  Millions
Nanoviricides inc   0.95 $ 1.126  Millions$ 1.182  Millions
Evoke Pharma Inc   0.95 $ 11.576  Millions$ 12.241  Millions
Quoin Pharmaceuticals Ltd   0.94 $ 5.431  Millions$ 5.765  Millions
Nanobiotix S a   0.92 $ 59.080  Millions$ 64.408  Millions
Geron Corporation  0.91 $ 79.993  Millions$ 87.712  Millions
Axsome Therapeutics Inc   0.90 $ 325.272  Millions$ 360.290  Millions
Zomedica Corp   0.89 $ 7.496  Millions$ 8.432  Millions
Prestige Consumer Healthcare Inc   0.88 $ 119.106  Millions$ 134.604  Millions
Eton Pharmaceuticals Inc   0.84 $ 37.121  Millions$ 44.183  Millions
Tg Therapeutics Inc   0.84 $ 131.582  Millions$ 156.810  Millions
Medicus Pharma Ltd   0.81 $ 8.662  Millions$ 10.658  Millions
Clearmind Medicine Inc  0.80 $ 2.800  Millions$ 3.491  Millions
Xeris Biopharma Holdings Inc   0.79 $ 91.598  Millions$ 116.200  Millions
Azitra Inc   0.78 $ 1.402  Millions$ 1.806  Millions
Bausch Health Companies Inc   0.77 $ 1,308.000  Millions$ 1,703.000  Millions
Igc Pharma Inc   0.75 $ 1.130  Millions$ 1.514  Millions
Verrica Pharmaceuticals Inc   0.73 $ 21.097  Millions$ 28.908  Millions
Inovio Pharmaceuticals Inc   0.73 $ 50.803  Millions$ 69.824  Millions
Ensysce Biosciences Inc   0.73 $ 1.673  Millions$ 2.305  Millions
Fibrobiologics Inc   0.72 $ 4.867  Millions$ 6.722  Millions
Aeon Biopharma inc   0.72 $ 5.927  Millions$ 8.228  Millions

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.